Large-scale testing (Phase 3)Study completedNCT02142075
What this trial is testing
Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure
Who this might be right for
Renal FailureCritical CareGram Positive Bacteria
Poitiers University Hospital